HilleVax (HLVX) Short Interest Ratio & Short Volume

Short interest is the volume of HilleVax shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 241,100 shares of HLVX short. 1.06% of HilleVax's shares are currently sold short. Learn More on HilleVax's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.06% of HilleVax's floating shares are currently sold short.

HilleVax saw a drop in short interest in the month of August. As of August 15th, there was short interest totaling 241,100 shares, a drop of 45.7% from the previous total of 444,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

HilleVax currently has issued a total of 50,140,000 shares. Some of HilleVax's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. HilleVax currently has a public float of 22,740,000 shares.

1.06% of HilleVax's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to HilleVax: Corvus Pharmaceuticals, Inc. (12.47%), Autolus Therapeutics PLC Sponsored ADR (5.60%), I-Mab Sponsored ADR (2.69%), Kamada Ltd. (0.22%), Aura Biosciences, Inc. (6.59%), Aquestive Therapeutics, Inc. (8.43%), Olema Pharmaceuticals, Inc. (12.36%), Y-mAbs Therapeutics, Inc. (4.81%), Vigil Neuroscience, Inc. (1.40%), Astria Therapeutics, Inc. (6.49%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks.

Short selling HLVX is an investing strategy that aims to generate trading profit from HilleVax as its price is falling. HLVX shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for HilleVax occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HLVX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HLVX, twice per month. The most recent reporting period available is August, 15 2025.